Full Length Research Paper
References
|
Arroyo MA, Hoelscher M, Sateren W, Maboko L, Hoffmann O, Kijak G, Robb M, Birx DL, Mccutchan FE (2005). HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. February, pp. 1517-1524. |
|
|
BBC (2020). Coronavirus: Africa will not be testing ground for vaccine. Says WHO. BBC.com. |
|
|
Braun V, Clarke V (2006). Using thematic analysis in psychology. Qualitative Research in Psychology 3(May 2015) :77-101. https://doi.org/10.1191/1478088706qp063oa |
|
|
Chenneville T, Gabbidon K, Hanson P, Holyfield C (2020). The impact of COVID-19 on HIV treatment and research: A call to action. In International Journal of Environmental Research and Public Health. |
|
|
Chin LJ, Berenson JA, Klitzman RL (2016). Typologies of altruistic and financial motivations for research participation: A qualitative study of MSM in HIV vaccine trials. Journal of Empirical Research on Human Research Ethics 11(4) :299-310. |
|
|
Communications and Global Advocacy UNAIDS (2020). UNAIDS FACT SHEET. Global HIV Statistics. Ending the AIDS Epidemic, pp. 1-3. |
|
|
Coutinho BA, Dtm MMPH (2020). Covid-19 in Africa: Scenarios and Signposts COVID-19 in Numbers Africa Has Growing Clinical Trial Experience Which. 10119. |
|
|
Detoc M, Bruel S, Frappe P, Botelho-Nevers E, Gagneux-Brunon A (2020). Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine, 38(45):7002-7006. 2020.04.23.20076513. |
|
|
Doshi M, Avery L, Kaddu RP, Gichuhi M, Gakii G, Du Plessis E, Dutta S, Khan S, Kimani J, Lorway RR (2017). Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials. BMC Public Health 17(1) :1-12. |
|
|
Fereday J (2006). Demonstrating Rigor Using Thematic Analysis?: A Hybrid Approach of Inductive and Deductive Coding and Theme Development. International Journal Of Qualitative Methods 5(1) :80-92. 80-92. |
|
|
Getz KA, Campo RA (2017). Trial watch: Trends in clinical trial design complexity. Nature Reviews Drug Discovery 16(5):307-308. |
|
|
Greenhalgh T, Taylor R (1997). How to read a paper: Papers that go beyond numbers (qualitative research). BMJ Clinical Research, 26(2):54-60. |
|
|
Hargreaves J, Davey C, Auerbach J, Blanchard J, Bond V, Bonell C, Burgess R, Busza J, Colbourn T, Cowan F, Doyle A, Hakim J, Hensen B, Hosseinipour M, Lin L, Johnson S, Masuka N, Mavhu W, Mugurungi O, Yekeye R (2020). Three lessons for the COVID-19 response from pandemic HIV. The Lancet HIV 7(5):e309-e311. |
|
|
Kamazima SR, Kakoko DCV, Kazaura M (2020). Manifold Tactics are used to Control and Prevent Pandemics in Contemporary Africa": A Case of Tanzania's Fight against COVID-19. International Journal of Advanced Scientific Research and Management 5(11):20. |
|
|
Koff WC (2012). HIV vaccine development: Challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem. Vaccine 30(29):4310-4315. |
|
|
Lin D, Sun S, Operario D, Normal B (2020).Willingness to Participate in a COVID-19 Vaccine Trial Among Young Adults in China. Available at SSRN 3615937. |
|
|
Lurie N, Saville M, Hatchett R, Halton J (2020).Developing Covid-19 vaccines at pandemic speed. New England Journal of Medicine 382(21):1969-1973. |
|
|
Mbunda T, Bakari M, Tarimo EA, Sandstrom E, Kulane A (2014). Factors that influence the willingness of young adults in Dar es Salaam, Tanzania, to participate in phase I/II HIV vaccine trials. Global Health Action 7(1):22853. |
|
|
Mfinanga SG, Mnyambwa NP, Minja DT, Ntinginya NE, Ngadaya E, Makani J, Makubi AN (2021). Correspondence Tanzania ' s position on the COVID-19 pandemic. The Lancet 6736(21):6736. |
|
|
Mills E, Cooper C, Guyatt G, Gilchrist A, Rachlis B, Sulway C, Wilson K (2004).Barriers to participating in an HIV vaccine trial: a systematic review. Aids 18(17):2235-2242. |
|
|
Newman PA, Duan N, Roberts KJ, Seiden D, Rudy ET, Swendeman D, Popova S (2006).HIV vaccine trial participation among ethnic minority communities: Barriers, motivators, and implications for recruitment. Journal of Acquired Immune Deficiency Syndromes |
|
|
Nyaoke BA, Mutua GN, Sajabi R, Nyasani D, Mureithi MW, Anzala OA (2017). Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya. PLoS One. |
|
|
Opeyemi US, Kayode AF, Nafisat UI (2017). O16.6 Willingness of young persons in south-western nigeria to participate in early hiv vaccine trials. |
|
|
Pronker ES, Weenen TC, Commandeur H, Claassen EHJHM, Osterhaus ADME (2013). Risk in Vaccine Research and Development Quantified. PLoS One. |
|
|
Tarimo EAM, Bakari M, Kakoko DCV, Kohi TW, Mhalu F, Sandstrom E, Kulane A (2016). Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania. BMC Public Health. |
|
|
Tarimo EAM, Ambikile J, Munseri P, Bakari M (2019). Perception of potential harm and benefits of HIV vaccine trial participation: A qualitative study from urban Tanzania. PLoS One. 1 |
|
|
Thabethe S, Slack C, Lindegger G, Wilkinson A, Wassenaar D, Kerr P, Bekker LG, Mngadi K, Newman PA (2018). "Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa. Journal of Empirical Research on Human Research Ethics. |
|
|
Thanh Le T, Andreadakis Z, Kumar A, Gómez RR, Tollefsen S, Saville M, Mayhew S (2020). The COVID-19 vaccine development landscape. In Nature reviews. Drug Discovery 19(5):305-306. |
|
|
THIS (2017). December 2017 Tanzania Hiv Impact Survey (THIS). December 2017 :2016-2017. |
|
|
Tong A, Sainsbury P, Craig J (2007). Consolidated criterio for reporting qualitative research (COREQ): a 32- item checklist for interviews and focus group. International Journal of Qualitative in Health Care 19(6):349-357. |
|
|
UNAIDS (2019). Global plan Country fact sheet-Tanzania. |
|
|
UNAIDS. (2020). AIDS Fact sheet: Global HIV statistics. |
|
|
World Health Organization (WHO) (2020). Coronavirus Disease 2019. In WHO (Vol. 14, Issue 6). |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
